CDNA
CareDx, Inc
NASDAQ · USHealthcareMedical - Diagnostics & Research
$38.37-3.42%
Price as of Jul 20, 2026
CDNA growth
CareDx, Inc growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +19.2%
- EBITDA
- +140.7%
- EBIT
- —
- EPS
- —
- Free cash flow
- +223.5%
- Operating cash flow
- +172.4%
Forward estimates
- Revenue
- +9.8%
- EBITDA
- —
- EPS
- +134.6%
Three-year CAGR
- Revenue
- +5.7%
- EBITDA
- +98.0%
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +14.4%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.